Literature DB >> 23062529

Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.

Mathias C Brandt1, Sara Reda, Felix Mahfoud, Matthias Lenski, Michael Böhm, Uta C Hoppe.   

Abstract

OBJECTIVES: This study investigated the effect of catheter-based renal sympathetic denervation (RD) on central hemodynamics in patients with resistant hypertension.
BACKGROUND: High central blood pressure (BP) increases cardiovascular events and mortality independently of peripheral BP. The effect of RD on central BP is unclear.
METHODS: A total of 110 patients underwent bilateral RD. Radial artery applanation tonometry and pulse wave analysis were used to derive central aortic pressure and hemodynamic indices at baseline and 1, 3, and 6 months after ablation. Ten patients with resistant hypertension not undergoing RD served as controls.
RESULTS: RD significantly reduced mean central aortic BP from 167/92 mm Hg to 149/88 mm Hg, 147/85 mm Hg, and 141/85 mm Hg at 1, 3, and 6 months (p < 0.001), respectively. Aortic pulse pressure decreased from 76.2 ± 23.3 mm Hg to 61.5 ± 17.5 mm Hg, 62.7 ± 18.1 mm Hg, and 54.5 ± 15.7 mm Hg 1, 3, and 6 months after RD (p < 0.001), respectively. Six months after RD aortic augmentation and augmentation index were significantly reduced by -11 mm Hg (p < 0.001) and -5.3% (p < 0.001), respectively. Carotid to femoral pulse wave velocity showed a significant reduction from 11.6 ± 3.2 m/s to 9.6 ± 3.1 m/s at 6 months (p < 0.001). Consistently, ejection duration and aortic systolic pressure load were significantly diminished, indicating improvement of cardiac work load by RD. No significant changes were obtained in control patients.
CONCLUSIONS: Besides the known effect of RD on brachial blood pressure, the study showed for the first time that this novel approach significantly improves arterial stiffness and central hemodynamics, which might have important prognostic implications in patients with resistant hypertension at high cardiovascular risk.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23062529     DOI: 10.1016/j.jacc.2012.08.959

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  45 in total

Review 1.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

Review 2.  Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Authors:  Vinay Gulati; William B White
Journal:  J Am Soc Hypertens       Date:  2013-08-15

Review 3.  Resistant Hypertension and Renal Nerve Denervation.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 4.  Novel and nonpharmacologic approaches to cardio-protection in hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Dominik Linz; Sebastian Ewen; Christian Ukena; Michael Böhm
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

5.  Renal denervation for resistant hypertension: yes.

Authors:  Enrico Boschetti; Yahya Alrashdi; Giuseppe Schillaci
Journal:  Intern Emerg Med       Date:  2016-03-12       Impact factor: 3.397

Review 6.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

Review 7.  Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Authors:  Matthew G Denker; Debbie L Cohen; Raymond R Townsend
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

Review 8.  Interventional treatment of hypertension: a new paradigm.

Authors:  W Schuyler Jones; Sreekanth Vemulapalli; Manesh R Patel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 9.  Renal denervation: a novel non-pharmacological approach in heart failure.

Authors:  Michael Böhm; Sebastian Ewen; Dominik Linz; Jan-C Reil; Stephan Schirmer; Christian Ukena; Felix Mahfoud
Journal:  J Cardiovasc Transl Res       Date:  2014-02-28       Impact factor: 4.132

10.  Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.

Authors:  Steven M Smith; Yan Gong; Eileen Handberg; Franz H Messerli; George L Bakris; Ali Ahmed; Anthony A Bavry; Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Hypertens       Date:  2014-03       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.